Prenatal Whole-exome Sequencing in a Russian Clinical Cohort: Diagnostic Yield, Indications, and Spectrum of Molecular Findings
- 20 August 2026
- journal article
- research article
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 20 (S2) , S178-S189
Abstract
Objective: Prenatal whole-exome sequencing (prWES) is a promising molecular diagnostic tool that can be used to clarify the genetic etiology of prenatally detected abnormalities, including cases in which standard genetic testing fails to establish their cause. However, data on its diagnostic yield and the spectrum of detectable abnormalities in Russian clinical practice remain limited. Objective: To perform a retrospective analysis of the indications for prWES, its diagnostic yield, and the spectrum of molecular findings in a Russian clinical cohort. Materials and methods: This retrospective cohort study included 485 pregnancies in which prWES was performed. Results: The most common indications for testing were fetal structural anomalies (43.71%), ultrasound markers of chromosomal abnormalities (24.74%), and adverse family history (21.65%). Pathogenic and likely pathogenic variants were identified in 73 of 485 cases (15.05%), variants of uncertain significance in 104 cases (21.24%), and secondary findings in 3 cases (0.62%). The highest diagnostic yield was observed in fetuses with structural anomalies, in whom pathogenic and likely pathogenic variants were detected in 17.92% of cases. In the group with ultrasound markers of chromosomal abnormalities, the diagnostic yield was 12.5%, whereas in cases with adverse family history it was 11.43%. Among the confirmed molecular disorders, skeletal dysplasias and connective tissue disorders (27.4%), Noonan syndrome and Noonan-related disorders (19.18%), and neurodevelopmental disorders (17.81%) predominated. Conclusion: prWES demonstrates high clinical utility in the diagnosis of fetal monogenic disorders and shows the greatest effectiveness in fetuses with structural anomalies and in families at high genetic risk. These findings may contribute to the optimization of prenatal diagnostic algorithms and genetic counseling strategies.Keywords
This publication has 20 references indexed in Scilit:
- An overview of current prenatal genetic screening and diagnosis guidelinesPregnancy, 2025
- Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public HealthcarePrenatal Diagnosis, 2025
- Incremental yield of exome sequencing over standard prenatal testing in structurally normal fetuses: systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2025
- Comprehensive prenatal diagnostics: Exome versus genome sequencingPrenatal Diagnosis, 2023
- Prenatal exome sequencing and impact on perinatal outcome: cohort studyUltrasound in Obstetrics & Gynecology, 2023
- Prenatal exome and genome sequencing for fetal structural abnormalitiesAmerican Journal of Obstetrics and Gynecology, 2022
- International Society for Prenatal Diagnosis Updated Position Statement on the use of genome‐wide sequencing for prenatal diagnosisPrenatal Diagnosis, 2022
- Lessons learnt from prenatal exome sequencingPrenatal Diagnosis, 2022
- Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta‐analysisPrenatal Diagnosis, 2022
- Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome‐wide sequencing for fetal diagnosisPrenatal Diagnosis, 2018